Patents by Inventor Doerthe Voss

Doerthe Voss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mutants for expressing mammalian glucose transporters
    Patent number: 8298812
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Grant
    Filed: November 9, 2009
    Date of Patent: October 30, 2012
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Guenter Mueller, Silke Dlugai, Doerthe Voss, Eckhard Boles
  • USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTERS
    Publication number: 20100203617
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Application
    Filed: November 9, 2009
    Publication date: August 12, 2010
    Applicant: SANOFI AVENTIS DEUTSCHLAND GMBH
    Inventors: Guenter MUELLER, Silke DLUGAI, Doerthe VOSS, Eckhard BOLES
  • Use of mutants for expressing mammalian glucose transporter
    Patent number: 7615360
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: November 10, 2009
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Guenter Mueller, Silke Dlugai, Doerthe Voss, Eckhard Boles
  • THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTER
    Publication number: 20080020419
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Application
    Filed: July 10, 2007
    Publication date: January 24, 2008
    Applicant: SANOFI AVENTIS DEUTSCHLAND GMBH
    Inventors: Guenter Mueller, Silke Dlugai, Doerthe Voss, Eckhard Boles
  • Use of erg4 mutants for expressing mammalian glucose transporters
    Patent number: 7244821
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Grant
    Filed: September 10, 2003
    Date of Patent: July 17, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Guenter Mueller, Silke Dlugai, Doerthe Voss, Eckhard Boles
  • Use of Saccharomyces cerevisiae Erg4 mutants for expressing mammalian glucose transporters
    Publication number: 20050074845
    Abstract: The invention relates to yeast strains in which a human GLUT4 transport or a human GLUT1 transporter can be functionally expressed and to particular GLUT4 transport proteins which can be functionally expressed particularly readily in yeast strains.
    Type: Application
    Filed: September 10, 2003
    Publication date: April 7, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Guenter Mueller, Silke Dlugai, Doerthe Voss, Eckhard Boles